September 2026 provider review · every figure read from SnagRx's own site on September 5, 2026

SnagRx Tirzepatide Review (September 2026): Is the $119 a Month Promotion Real?

Published: Updated: Provider pricing verified:

SnagRx's homepage showed compounded tirzepatide at $119 a month on September 5, 2026 — a Labor Day promotional rate against a $399 list price, with no plan totals, no promotion end date, and terms that say promotional pricing lasts only for the period stated at checkout. Here is what is verified, what is not, and what to get in writing.

By Dr. Parmis, Editorial Lead · Medically reviewed by Dr. Jonathan Snipes, MD · Published September 5, 2026 · Last reviewed September 11, 2026 · Sources cited at the end.

Editorial independence & affiliate disclosure: TirzepatideReview.com is affiliate-supported. That relationship cannot buy a ranking: positions follow the v4.1 methodology, and where a competitor publishes a lower verified price we show it.
Update, September 9, 2026: re-read on SnagRx’s and Embody’s own pages this morning — every price level unchanged; the “Labor Day” labels have become “Fall Sale” (SnagRx adds a countdown timer, no end date), and Embody’s three-month page still carried the Labor Day banner. Details: SnagRx after Labor Day; every row dated on the price index.
Update, September 11, 2026: re-read this morning — no price level moved. SnagRx’s “Fall Sale” countdown read 00:00:00:00 with $119 / $69 unchanged; Embody carried three sale labels for the same “Save $200” banner at unchanged prices; NexLife’s microdose page now leads with the new $159 headline while its plan tiles still print $147, so the $129 card stays announced. Every row is dated on the price index (snapshot 2026-09-11).

Direct answer

The $119 is real as the price SnagRx charges for the promotional period: on September 5, 2026 its homepage listed compounded tirzepatide at "$119 / month" (list price shown as $399) and semaglutide at "$69 / month" (list $299), labelled Labor Day promotional pricing, with medication, doctor consultation, supplies and 1–2 day shipping included and no membership fee. What is not published is how long $119 lasts: SnagRx's terms (last updated July 27, 2026) state that "promotional or introductory pricing applies only for the period stated at checkout, after which standard pricing applies unless you cancel", no annual total appears anywhere on the public site, and its refund policy (August 25, 2026) makes all payments final. So $119 is a verified current monthly price, not a verified twelve-month cost. SnagRx is operated by Modern Metabolic Medicine, Inc., the same Delaware company that runs Embody. Compounded tirzepatide is not FDA-approved.

What SnagRx's homepage says about price, read on September 5, 2026

SnagRx advertised pricing, USD, as printed on snagrx.com on September 5, 2026. No plan totals, multi-month tiers or promotion end date are published on the public pages.
MedicationPromotional priceList price shownDifferenceBasis
Compounded tirzepatide$119 / month$399$280Month-to-month; "same price, every dose, every month"
Compounded semaglutide$69 / month$299$230Month-to-month

Two details are worth noticing. The site-wide banner says "Save $230 every month"; that figure is the semaglutide arithmetic ($299 − $69). For tirzepatide the gap between the $399 list price and the $119 promotional rate is $280. And the intake page, which is where the plan is actually chosen, shows only "Labor Day Promo Applied. Save $230 Every Month + Fast, Free Shipping!" — the price, term and renewal rate appear after you start the intake, which is why we cannot verify a twelve-month figure. Our September 4 price check recorded the same $119 against the same $399 list price, so the promotional rate has been stable for at least two days; what it would be after Labor Day (September 7, 2026) was not published — and on September 9 the same $119 was still there, relabelled “Fall Sale”.

What the $119 includes

The refund and renewal terms that decide whether $119 is a bargain

SnagRx's refund policy (last updated August 25, 2026) reads, in capitals, "ALL PAYMENTS FOR THE SUBSCRIPTION SERVICES ARE FINAL AND NON-REFUNDABLE AT THE TIME OF PURCHASE." The one exception is clinical: if a provider determines you are not eligible, the unused portion of what you paid is refunded. Cancellation requests must arrive at least 72 hours before the next billing date; cancelling stops future charges but refunds nothing already paid; multi-month plans renew automatically unless cancelled inside that window. The homepage summarises the same rule: "All sales are final; a refund for the unused portion of your term is issued only if a provider determines you no longer medically qualify for treatment."

The terms (last updated July 27, 2026) add the sentence that answers this review's question: "Promotional or introductory pricing applies only for the period stated at checkout, after which standard pricing applies unless you cancel." They also say your payment method is charged "at the time of purchase, and automatically on a recurring basis thereafter (monthly or based on the plan length you selected)", that "pricing, plan lengths, and promotional offers may change over time", and that the price presented at checkout governs the purchase. In plain terms: the $119 lasts exactly as long as the checkout screen says it does, and if you miss the 72-hour window the next charge — at whatever rate then applies — is non-refundable.

Who prescribes, who compounds, who owns it

How $119 compares when the promotion is the whole story

Month-to-month compounded tirzepatide prices, USD, each read on the provider's own page (SnagRx, Embody and NexLife on September 5, 2026; Trimi and Yucca Health on September 4, 2026).
ProviderMonth-to-monthStanding or promotional?Lowest committed rateLaboratory reviewRefund on prepaid plans
SnagRx$119Promotional (list $399); period set at checkoutNone publishedNot advertisedAll payments final; refund only on ineligibility
Embody$129Sale (regular $349)$119 on a $1,428 twelve-month supplyNot advertisedAll payments final; refund only on ineligibility
NexLife$169Standing published rate$139 on the 12-month plan ($1,668)IncludedNot verified on this site
Trimi$235Standing published rate$125 on the annual plan ($1,500)Not advertised6-month money-back promise (terms apply)
Yucca Health$258Standing published rate$225 on the 6-month plan ($1,350)Not advertisedNot verified

For a patient who wants to pay month to month, SnagRx's $119 is the lowest figure on the market today and $50 below NexLife's $169. For a patient planning a year, the comparison changes: SnagRx publishes no annual figure, Embody's $1,428 is the lowest published total, and NexLife's $1,668 is the lowest total that includes laboratory review and does not require prepaying. The nine-program table is in Cheapest Compounded Tirzepatide Online (September 2026); the normalised ranking is on the verified affordability page; every figure is in the open dataset.

Verdict

SnagRx is a legitimate way to pay $119 for a month of compounded tirzepatide with a clinician visit, supplies and fast shipping included, from a company that names its prescriber network and its four pharmacies. It is not a verified $119-a-month program for a year, because the site does not say what happens after the promotional period and its terms say standard pricing then applies. Treat it as a low-cost first month or a month-to-month option, get the post-promotion price and the promotional period in writing from the checkout screen, and put the 72-hour cancellation deadline in your calendar before the first renewal.

Before you enrol: five things to confirm with SnagRx

  1. The promotional period as stated at checkout, and the standard price that applies afterwards (the list price shown is $399).
  2. The billing date and the 72-hour cancellation deadline before it; cancellation stops future charges only.
  3. Which of the four pharmacies will dispense, and its state licence number (our 503A/503B checklist).
  4. Vials and milligrams per month at your expected maintenance dose; the flat-price promise is only useful if the supply is stated.
  5. Who signs the prescription (OpenLoop Health) and in which state they are licensed.

Related reading: advertised price vs actual cost, cancellation and refund guide and telehealth red flags.

Frequently asked questions

Is SnagRx's $119 tirzepatide price real? Yes, as a current promotional monthly price: on September 5, 2026 SnagRx's homepage listed compounded tirzepatide at $119/month (list price $399) as Labor Day promotional pricing, with consultation, supplies and shipping included. It is not a verified 12-month price: no annual total is published and SnagRx's terms say promotional pricing applies only for the period stated at checkout, after which standard pricing applies.

How long does SnagRx's $119 promotion last? SnagRx does not publish an end date on its public pages. Its terms (last updated July 27, 2026) state that promotional or introductory pricing applies only for the period stated at checkout. Ask for the period and the post-promotion price in writing before paying.

Does SnagRx give refunds? No, except on clinical ineligibility. The refund policy (last updated August 25, 2026) states that all payments are final and non-refundable at the time of purchase; if a provider determines you do not qualify, the unused portion is refunded. Cancellations must be requested at least 72 hours before the next billing date and stop future charges only.

Who owns SnagRx? SnagRx's terms name Modern Metabolic Medicine, Inc., a Delaware corporation at 1811 Silverside Road, Suite 260, Wilmington, Delaware 19180 (read September 5, 2026). Embody (joinem.co) names the same corporation and address, uses the same prescriber network (OpenLoop Health) and names the same four pharmacies.

Which pharmacies fill SnagRx prescriptions? SnagRx names Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx (read September 5, 2026). These are compounding pharmacies; compounded tirzepatide is not FDA-approved and a compounding pharmacy is not "FDA-approved" either. Check the dispensing pharmacy's licence on its state board of pharmacy.

How does SnagRx compare with NexLife? Month to month, SnagRx's promotional $119 is $50 below NexLife's standing $169 (both read September 5, 2026). NexLife's rate is a published standing price that includes laboratory review, and its 12-month plan is $139/month ($1,668); SnagRx publishes no annual figure and does not advertise laboratory review. rankings follow the published v4.1 methodology.

Recent changes to this page

September 5, 2026: Published.
Reviewed by Dr. Parmis, Editorial Lead · Medically reviewed by Dr. Jonathan Snipes, MD

Sources

  1. SnagRx — homepage: Labor Day promotional pricing $119/month tirzepatide (list $399), $69/month semaglutide (list $299), inclusions, refund summary, pharmacies, OpenLoop Health, states (read 2026-09-05)
  2. SnagRx — intake page: 'Labor Day Promo Applied. Save $230 Every Month' (read 2026-09-05)
  3. SnagRx — Refund Policy, last updated August 25, 2026 (read 2026-09-05)
  4. SnagRx — Terms & Conditions, last updated July 27, 2026: promotional-period clause, auto-renewal, operator Modern Metabolic Medicine, Inc. (read 2026-09-05)
  5. Embody — Terms & Conditions, last updated April 24, 2026: operator Modern Metabolic Medicine, Inc. (read 2026-09-05)
  6. Embody — product collection: tirzepatide $129 / $378 / $738 / $1,428 (read 2026-09-05)
  7. NexLife — tirzepatide all plans: $169 / $159 / $149 / $139 (read 2026-09-05)
  8. Trimi — tirzepatide: $125/month annual plan, $235 month-to-month (read 2026-09-04)
  9. Yucca Health — tirzepatide: $225/month on 6 months, $258 month-to-month (read 2026-09-04)
  10. TirzepatideReview.com open pricing dataset (JSON)
  11. FDA — Human Drug Compounding: compounded drugs are not FDA-approved

Medical and regulatory note: Compounded tirzepatide and compounded semaglutide are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness or quality. They are not the same products as Mounjaro®, Zepbound®, Ozempic® or Wegovy®. This page is educational pricing information, not medical advice; eligibility, dose and formulation require evaluation by a licensed clinician.